Article

Lee, S. M., Woll, P. J., Rudd, R., Ferry, D., O'Brien, M., Middleton, G., Spiro, S., James, L., Ali, K., Jitlal, M., Hackshaw, A. (2009) Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 101 (15). pp. 1049-1057. ISSN 0027-8874

Lee, S. M., James, L. E., Qian, W., Spiro, S., Eisen, T., Gower, N. H., Ferry, D. R., Gilligan, D., Harper, P. G., Prendiville, J., Hocking, M., Rudd, R. M. (2009) Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. THORAX, 64 (1). pp. 75-80. ISSN 0040-6376

Muers, M. F., Stephens, R. J., Fisher, P., Darlison, L., Higgs, C. M. B., Lowry, E., Nicholson, A. G., O'Brien, M., Peake, M., Rudd, R., Snee, M., Steele, J., Girling, D. J., Nankivell, M., Pugh, C., Parmar, M. K. B., MS01 Trial Management Grp, [Group Author] (2008) Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial. LANCET, 371 (9625). pp. 1685-1694. ISSN 0140-6736

Panakis, N., McNair, H. A., Christian, J. A., Mendes, R., Symonds-Tayler, J. R., Knowles, C., Evans, P. M., Bedford, J., Brada, M. (2008) Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters. RADIOTHERAPY AND ONCOLOGY, 87 (1). pp. 65-73. ISSN 0167-8140

Carden, C. P., Myerson, J. S., Popat, S., Montes, A., Larkin, J. M. G., Benson, M. J., O'Brien, M. E. R. (2008) Good vibrations and the power of positron thinking: Positron emission tomography and endoscopic ultrasound in staging of mesothelioma - Two case reports. JOURNAL OF THORACIC ONCOLOGY, 3 (5). pp. 539-541. ISSN 1556-0864

Moore, S., Teehan, C., Cornwall, A., Ball, K., Thomas, J. (2008) 'Hands of Time': the experience of establishing a support group for people affected by mesothelioma. EUROPEAN JOURNAL OF CANCER CARE, 17 (6). pp. 585-592. ISSN 0961-5423

Santoro, A., O'Brien, M. E., Stahel, R. A., Nackaerts, K., Baas, P., Karthaus, M., Eberhardt, W., Paz-Ares, L., Sundstrom, S., Liu, Y., Ripoche, V., Blatter, J., Visseren-Grul, C. M., Manegold, C. (2008) Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaive patients with malignant pleural mesothelioma: Results of the International Expanded Access Program. JOURNAL OF THORACIC ONCOLOGY, 3 (7). pp. 756-763. ISSN 1556-0864

Paz-Ares, L., Ross, H., O'Brien, M., Riviere, A., Gatzemeier, U., Von Pawel, J., Kaukel, E., Freitag, L., Digel, W., Bischoff, H., Garcia-Campelo, R., Iannotti, N., Reiterer, P., Bover, I., Prendiville, J., Eisenfeld, A. J., Oldham, F. B., Bandstra, B., Singer, J. W., Bonomi, P. (2008) Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. BRITISH JOURNAL OF CANCER, 98 (10). pp. 1608-1613. ISSN 0007-0920

O'Brien, M. E. R., Socinski, M. A., Popovich, A. Y., Bondarenko, I. N., Tomova, A., Bilynskyi, B. T., Hotko, Y. S., Ganul, V. L., Kostinsky, I. Y., Eisenfeld, A. J., Sandalic, L., Oldham, F. B., Bandstra, B., Sandler, A. B., Singer, J. W. (2008) Randomized phase III trial comparing single-agent paclitaxel poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer. JOURNAL OF THORACIC ONCOLOGY, 3 (7). pp. 728-734. ISSN 1556-0864

Brock, J., Ashley, S., Bedford, J., Nioutsikou, E., Partridge, M., Brada, M. (2008) Review of Hypofractionated Small Volume Radiotherapy for Early-stage Non-small Cell Lung Cancer. CLINICAL ONCOLOGY, 20 (9). pp. 666-676. ISSN 0936-6555

Stanford, J. L., Stanford, C. A., O'Brien, M. E. R., Grange, J. M. (2008) Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung. EUROPEAN JOURNAL OF CANCER, 44 (2). pp. 224-227. ISSN 0959-8049

O'Brien, M. E. R., Yau, T., Coward, J., Hughes, S., Papadopoulos, P., Popat, S., Norton, A., Ashley, S. (2008) Time and chemotherapy treatment trends in the treatment of elderly patients (age >= 70 years) with non-small cell lung cancer. CLINICAL ONCOLOGY, 20 (2). pp. 142-147. ISSN 0936-6555

Richardson, A., Plant, H., Moore, S., Medina, J., Cornwall, A., Ream, E. (2007) Developing supportive care for family members of people with lung cancer: a feasibility study. SUPPORTIVE CARE IN CANCER, 15 (11). pp. 1259-1269. ISSN 0941-4355

Sirohi, B., Ashley, S., Norton, A., Popat, S., Hughes, S., Papadopoulos, P., Priest, K., O'Brien, M. (2007) Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival. JOURNAL OF THORACIC ONCOLOGY, 2 (8). pp. 735-740. ISSN 1556-0864

Lavrenkov, K., Christian, J. A., Partridge, M., Niotsikou, E., Cook, G., Parker, M., Bedford, J. L., Brada, M. (2007) A potential to reduce pulmonary toxicity: The use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-smalt cell lung cancer. RADIOTHERAPY AND ONCOLOGY, 83 (2). pp. 156-162. ISSN 0167-8140

Gilligan, D., Nicolson, M., Smith, I., Groen, H., Dalesio, O., Goldstraw, P., Hatton, M., Hopwood, P., Manegold, C., Schramel, F., Smit, H., van Meerbeeck, J., Nankivell, M., Parmar, M., Pugh, C., Stephens, R. (2007) Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. LANCET, 369 (9577). pp. 1929-1937. ISSN 0140-6736

Popat, S., Hughes, S., Papadopoulos, P., Wilkins, A., Moore, S., Priest, K., Meehan, L., Norton, A., O'Brien, M. (2007) Recurrent responses to non-small cell lung cancer brain metastases with erlotinib. LUNG CANCER, 56 (1). pp. 135-137. ISSN 0169-5002

Khalid, U., Spiro, A., Baldwin, C., Sharma, B., McGough, C., Norman, A. R., Eisen, T., O'Brien, M. E. R., Cunningham, D., Andreyev, H. J. N. (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. SUPPORTIVE CARE IN CANCER, 15 (1). pp. 39-46. ISSN 0941-4355

Banerji, U., Ashley, S., Coward, J., Hughes, S., Zee, Y., Benepal, T., Norton, A., Eisen, T., O'Brien, M. (2006) The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer. LUNG CANCER, 54 (3). pp. 371-377. ISSN 0169-5002

Mendes, R., Lavrenkov, K., Bedford, J. L., Henrys, A., Ashley, S., Brada, M. (2006) Comparison of forward planning with automated inverse planning for three-dimensional conformal radiotherapy of non-small cell lung cancer without IMRT. RADIOTHERAPY AND ONCOLOGY, 78 (3). pp. 322-325. ISSN 0167-8140

Matakidou, A., Eisen, T., Fleischmann, C., Bridle, H., Houlston, R. S., GELCAPS Consortium, [Group Author] (2006) Evaluation of xeroderma pigmentosum XPA, XPC, XPD, XPF, XPB, XPG and DDB2 genes in familial early-onset lung cancer predisposition. INTERNATIONAL JOURNAL OF CANCER, 119 (4). pp. 964-967. ISSN 0020-7136

Swanton, C., Futreal, A., Eisen, T. (2006) Her2-targeted therapies in non-small cell lung cancer. CLINICAL CANCER RESEARCH, 12 (14). 4377S-4383S. ISSN 1078-0432

O'Brien, M. E., Ciuleanu, T. E., Tsekov, H., Shparyk, Y., Cucevia, B., Juhasz, G., Thatcher, N., Ross, G. A., Dane, G. C., Crofts, T. (2006) Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. JOURNAL OF CLINICAL ONCOLOGY, 24 (34). pp. 5441-5447. ISSN 0732-183X

Booton, R., Lorigan, P., Anderson, H., Baka, S., Ashcroft, L., Nicolson, M., O'Brien, M., Dunlop, D., O'Byrne, K., Laurence, V., Snee, M., Dark, G., Thatcher, N. (2006) A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1). ANNALS OF ONCOLOGY, 17 (7). pp. 1111-1119. ISSN 0923-7534

O'Brien, M. E. R., Watkins, D., Ryan, C., Priest, K., Corbishley, C., Norton, A., Ashley, S., Rowell, N., Sayer, R. (2006) A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial. ANNALS OF ONCOLOGY, 17 (2). pp. 270-275. ISSN 0923-7534

Yau, T., Ashley, S., Popat, S., Norton, A., Matakidou, A., Coward, J., O'Brien, M. E. R. (2006) Time and chemotherapy treatment trends in the treatment of elderly patients (age >= 70 years) with small cell lung cancer. BRITISH JOURNAL OF CANCER, 94 (1). pp. 18-21. ISSN 0007-0920

Bennouna, J., Breton, J. L., Tourani, J. M., Ottensmeier, C., O'Brien, M., Kosmidis, P., Huat, T. E., Pinel, M. C., Colin, C., Douillard, J. Y. (2006) Vinflunine - an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study. BRITISH JOURNAL OF CANCER, 94 (10). pp. 1383-1388. ISSN 0007-0920

Blohmer JU, Dunst J, Harrison L, Johnston P, Khayat D, Ludwig H, O'Brien M, Van Belle S, Vaupel P (2005) Cancer-related anemia: Biological findings, clinical implications and impact on quality of life. ONCOLOGY, 68 (Supplement 1). pp. 12-21. ISSN 0030-2414

Matakidou A, Eisen T, Bridle H, O'Brien M, Mutch R, Houlston RS (2005) Case-control study of familial lung cancer risks in UK women. INTERNATIONAL JOURNAL OF CANCER, 116 (3). pp. 445-450. ISSN 0020-7136

Rudd RM, Gower NH, Spiro SG, Eisen TG, Harper PG, Littler JAH, Hatton M, Johnson PWM, Martin WMC, Rankin EM, James LE, Gregory WM, Qian W, Lee SM (2005) Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: A phase III randomized study of the London Lung Cancer Group. JOURNAL OF CLINICAL ONCOLOGY, 23 (1). pp. 142-153. ISSN 0732-183X

Scagliotti, G. V., Kortsik, C., Dark, G. G., Price, A., Manegold, C., Rosell, R., O'Brien, M., Peterson, P. M., Castellano, D., Selvaggi, G., Novello, S., Blatter, J., Kayitalire, L., Crino, L., Paz-Ares, L. (2005) Pemetrexed combined with oxaliplatin or carboplatin as first- line treatment in advanced non-small cell lung cancer a multicenter, randomized, phase II trial. CLINICAL CANCER RESEARCH, 11 (2). pp. 690-696. ISSN 1078-0432

Scagliotti GV, Smit E, Bosquee L, O'Brien M, Ardizzoni A, Zatloukal P, Eberhardt W, Smid-Geirnaerdt M, de Bruin HG, Dussenne S, Legrand C, Giaccone G (2005) A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956). LUNG CANCER, 50 (1). pp. 91-96. ISSN 0169-5002

Giaccone, G., Debruyne, C., Felip, E., Chapman, P. B., Grant, S. C., Millward, M., Thiberville, L., D'Addario, G., Coens, C., Rome, L. S., Zatloukal, P., Masso, O., Legrand, C. (2005) Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-0897113; Silva Study). JOURNAL OF CLINICAL ONCOLOGY, 23 (28). pp. 6854-6864. ISSN 0732-183X

Lavrenkov, K., Partridge, M., Cook, G., Brada, M. (2005) Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer. RADIOTHERAPY AND ONCOLOGY, 77 (1). pp. 1-4. ISSN 0167-8140

Lorigan, P., Woll, P. J., O'Brien, M. E. R., Ashcroft, L. F., Sampson, M. R., Thatcher, N. (2005) Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 97 (9). pp. 666-674. ISSN 0027-8874

Muers, M. F., Rudd, R. M., O'Brien, M. E. R., Qian, W., Hodson, A., Parmar, M. K. B., Girling, D. J. on behalf of the British Thoracic Society Mesothelioma Group (2004) BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112. THORAX, 59 (2). pp. 144-148. ISSN 0040-6376

Ross, P. J., Ashley, S., Norton, A., Priest, K., Waters, J. S., Eisen, T., Smith, I. E., O'Brien, M. E. R. (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? BRITISH JOURNAL OF CANCER, 90 (10). pp. 1905-1911. ISSN 0007-0920

O'Brien MER (2004) Malignant mesothelioma - the UK experience. LUNG CANCER, 45 (Supplement 1). S133-S135. ISSN 0169-5002

Andreopoulou, E., Ross, P. J., O'Brien, M. E. R., Ford, H. E. R., Priest, K., Eisen, T., Norton, A., Ashley, S., Smith, I. E. (2004) The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma. ANNALS OF ONCOLOGY, 15 (9). pp. 1406-1412. ISSN 0923-7534

O'Brien, M. E., Anderson, H., Kaukel, E., O'Byrne, K., Pawlicki, M., Von Pawel, J., Reck, M. (2004) SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. ANNALS OF ONCOLOGY, 15 (6). pp. 906-914. ISSN 0923-7534

O'Brien, M. E., Szczesna, A., Karnicka, H., Zatloukal, P., Eisen, T., Hartmann, W., Kasan, P., Longerey, B., Lefresne, F. (2004) Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II study. ANNALS OF ONCOLOGY, 15 (6). pp. 921-927. ISSN 0923-7534

O'Brien MER, Splinter T, Smit EF, Biesma B, Krzakowski M, Tjan-Heijnen VCG, Van Bochove A, Stigt J, Smid-Geirnaerdt MJA, Debruyne C, Legrand C, Giaccone G (2003) Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer: an EORTC phase II study (EORTC 08958). EUROPEAN JOURNAL OF CANCER, 39 (10). pp. 1416-1422. ISSN 0959-8049

Murray PV, O'Brien MER, Sayer R, Cooke N, Knowles G, Miller AC, Varney V, Rowell NP, Padhani AR, MacVicar D, Norton A, Ashley S, Smith IE (2003) The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathway. LUNG CANCER, 42 (3). pp. 283-290. ISSN 0169-5002

Mackay HJ, O'Brien M, Hill S, Lees SM, Thatcher N, Smith IE, Dunlop DJ (2003) A phase II study of carboplatin and vinorelbine in patients with poor prognosis small cell lung cancer. CLINICAL ONCOLOGY, 15 (4). pp. 181-185. ISSN 0936-6555

Matakidou, A., Eisen, T., Houlston, R. S. (2003) TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. MUTAGENESIS, 18 (4). pp. 377-385. ISSN 0267-8357

Waters, J. S., O'Brien, M. E. R. (2002) The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE). BRITISH JOURNAL OF CANCER, 87 (5). pp. 481-490. ISSN 0007-0920

Mendes, R., O'Brien, M. E. R., Mitra, A., Norton, A., Gregory, R. K., Padhani, A. R., Bromelow, K. V., Winkley, A. R., Ashley, S., Smith, I. E., Souberbielle, B. E. (2002) Clinical and immunological assessment of Mycobacterium vaccae (SRL 172) with chemotherapy in patients with malignant mesothelioma. BRITISH JOURNAL OF CANCER, 86 (3). pp. 336-341. ISSN 0007-0920

Moore, S., Corner, J., Haviland, J., Wells, M., Salmon, E., Normand, C., Brada, M., O'Brien, M., Smith, I. (2002) Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BRITISH MEDICAL JOURNAL, 325 (7373). pp. 1145-1147. ISSN 0007-1447

Assersohn L, Souberbielle BE, O'Brien MER, Archer CD, Mendes R, Bass R, Bromelow KV, Palmer RD, Bouilloux E, Kennard DA, Smith IE (2002) A randomized pilot study of SRL172 (Mycobacterium vaccae) in patients with small cell lung cancer (SCLC) treated with chemotherapy. CLINICAL ONCOLOGY, 14 (1). pp. 23-27. ISSN 0936-6555

Smith IE, O'Brien MER, Talbot DC, Nicolson MC, Mansi JL, Hickish TF, Norton A, Ashey S (2001) Duration of chemotherapy in advanced non-small-cell lung cancer: A randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin. JOURNAL OF CLINICAL ONCOLOGY, 19 (5). pp. 1336-1343. ISSN 0732-183X

Dowsett, M., Bundred, N. J., Decensi, A., Sainsbury, R. C., Lu, Y. L., Hills, M. J., Cohen, F. J., Veronesi, P., O'Brien, M. E. R., Scott, T., Muchmore, D. B. (2001) Effect of raloxifene on breast cancer cell Ki67 and apoptosis: A double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 10 (9). pp. 961-966. ISSN 1055-9965

Gregory RK, Smith IE, Norton A, Ashley S, O'Brien MER (2001) Mitomycin C, Vinblastine and Carboplatin: effective outpatient chemotherapy for advanced non-small cell carcinoma of the lung (NSCLC). CLINICAL ONCOLOGY, 13 (6). pp. 483-487. ISSN 0936-6555

Jassem, J., Ramlau, R., Karnicka-Modkowska, H., Krawczyk, K., Krzakowski, M., Zatlowkal, P., Lemarié, E., Hartmann, W., Novakova, L., O'Brien, M., Depierre, A. (2001) A multicenter randomized phase II study of oral vinorelbine vs intravenous vinorelbine in advanced non-small cell lung cancer patients. ANNALS OF ONCOLOGY, 12 (10). pp. 1375-1381. ISSN 0923-7534

Bromelow KV, Hirst W, Mendes RL, Winkley AR, Smith IE, O'Brien MER, Souberbielle BE (2001) Whole blood assay for assessment of the mixed lymphocyte reaction. JOURNAL OF IMMUNOLOGICAL METHODS, 247 (1-2). pp. 1-8. ISSN 0022-1759

Book Section

Gregory K, O'Brien M. (2003) Lung cancer. In: UNSPECIFIED, (ed.) Cancer in Primary Care. Martin Dunitz, London, UK, pp. 89-96. ISBN 978-190186526-4

Editorial

Swanton, C., Burrell, R. A. (2009) Advances in personalized therapeutics in non-small cell lung cancer 4q12 amplification, PDGFRA oncogene addiction and sunitinib sensitivity. [Editorial]

Carden, C. P., O'Brien, M. E. R. (2008) Small-cell lung cancer, getting smaller but still difficult to treat. [Editorial]

Lynch, T. J., Adjei, A. A., Bunn, P. A., Eisen, T. G., Engelman, J., Goss, G. D., Haber, D. A., Heymach, J. V., Janne, P. A., Johnson, B. E., Johnson, D. H., Lilenbaum, R. C., Meyerson, M., Sandler, A. B., Sequist, L. V., Settleman, J., Wong, K. K., Hart, C. S. (2006) Summary statement: Novel agents in the treatment of lung cancer: Advances in epidermal growth factor receptor-targeted agents. [Editorial]

Panakis, N., Nutting, C. (2004) Radical treatment of non-small cell lung cancer - A meeting of the British Institute of Radiology, held at the Royal Marsden Hospital, Thursday 5th February 2004. [Editorial]

Bunn PA, Smith IE (2003) Pemetrexed (Alimta): Advancing the treatment of malignant pleural mesothelioma, non-small cell lung, pancreas, and other cancers - Introduction. [Editorial]

Rees C, O'Brien MER (2001) Palliative radiotherapy for lung cancer: Is it enough? [Editorial]

Letter

Harper-Wynne CL, Sumpter K, Ryan C, Priest K, Norton A, Ross P, Ford HER, Johnson P, O'Brien MER (2005) Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control. [Letter]

Rudd RM, Gower NH, Spiro SG, Lee SM, Eisen TG, Harper PG, Hatton M, Martin WMC, Rankin EM (2005) Is the tolerance to MIP chemotherapy different between English and other European populations? - Reply. [Letter]

Sumpter K, Harper-Wynne C, Yeoh C, Popat S, Ashley S, Norton A, O'Brien M (2004) Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible? [Letter]

Macbeth F, Stephens R, Abratt RP, Arriagada R, Batt D, Bezjak A, Billingham L, Crowley J, O'Brien M, Shakespeare T, Thompson E, van Meerbeeck J (2004) An open letter to all members of the IASLC. [Letter]

Sumpter K, Harper-Wynne C, O'Brien M, Congleton J (2004) Severe acute interstitial pnuemonia and gefitinib. [Letter]

Waters JS, O'Brien MER, Ashley S (2002) Management of anemia in patients receiving chemotherapy. [Letter]

Pandha HS, Mortimer P, Souberbeille B, McCoubrie PM, O'Brien MER (2001) Cutaneous toxicity after intradermal vaccination with Mycobacterium vaccae against lung cancer and malignant mesothelioma. [Letter]

Murray, P., O'Brien, M. (2001) Pulmonary infiltrates in non-HIV patients. [Letter]

Review Article

Devaraj, A., Cook, G. J. R., Hansell, D. M. (2007) PET/CT in non-small cell lung cancer staging - promises and problems. CLINICAL RADIOLOGY, 62 (2). pp. 97-108. ISSN 0009-9260

Spicer, J., Chowdhury, S., Harper, P. (2007) Targeting novel and established therapies for non-small cell lung cancer. CANCER LETTERS, 250 (1). pp. 9-16. ISSN 0304-3835

Nicum, S. J., O'Brien, M. E. R. (2007) Topotecan for the treatment of small-cell lung cancer. EXPERT REVIEW OF ANTICANCER THERAPY, 7 (6). pp. 795-801. ISSN 1473-7140

Popat S, O'Brien M (2005) Chemotherapy strategies in the treatment of small cell lung cancer. ANTI-CANCER DRUGS, 16 (4). pp. 361-372. ISSN 0959-4973

Matakidou, A., Eisen, T., Houlston, R. S. (2005) Systematic review of the relationship between family history and lung cancer risk. BRITISH JOURNAL OF CANCER, 93 (7). pp. 825-833. ISSN 0007-0920